These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35260724)

  • 21. Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
    Potdar AA; Dube S; Naito T; Li K; Botwin G; Haritunians T; Li D; Casero D; Yang S; Bilsborough J; Perrigoue JG; Denson LA; Daly M; Targan SR; Fleshner P; Braun J; Kugathasan S; Stappenbeck TS; McGovern DPB
    Gastroenterology; 2021 Feb; 160(3):809-822.e7. PubMed ID: 33160965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
    Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
    Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.
    Sauter JL; Baine MK; Butnor KJ; Buonocore DJ; Chang JC; Jungbluth AA; Szabolcs MJ; Morjaria S; Mount SL; Rekhtman N; Selbs E; Sheng ZM; Xiao Y; Kleiner DE; Pittaluga S; Taubenberger JK; Rapkiewicz AV; Travis WD
    Histopathology; 2020 Dec; 77(6):915-925. PubMed ID: 32614086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.
    Oz M; Lorke DE
    Biomed Pharmacother; 2021 Apr; 136():111193. PubMed ID: 33461019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to recombinant SARS-CoV-2 spike protein entry in the lungs of high-fat diet-induced obese mice.
    Gotoh K; Satoh F; Uesugi H; Noguchi T; Matsuda N; Sada K; Miyamoto S; Ozeki Y; Yoshida Y; Okamoto M; Masaki T; Kawabe T; Shibata H
    FASEB J; 2024 May; 38(10):e23656. PubMed ID: 38752523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
    Zhang Z; Guo L; Lu X; Zhang C; Huang L; Wang X; Duan F; Liang H; Chen P; Zeng L; Shao J; Li H; Li L; Liu L; Li C; Zhang J; Ma CY; Kwan KY; Liu W; Xu Y; Gu X; Jiang H; Du H; Zhang T; Wu Y; Yu G; Chen J; Luo R; Liao C; Tse HF; Chen Z; Chen HJ; Xia H; Lian Q
    Theranostics; 2021; 11(5):2170-2181. PubMed ID: 33500718
    [No Abstract]   [Full Text] [Related]  

  • 28. Protein expression of angiotensin-converting enzyme 2, a SARS-CoV-2-specific receptor, in fetal and placental tissues throughout gestation: new insight for perinatal counseling.
    Faure-Bardon V; Isnard P; Roux N; Leruez-Ville M; Molina T; Bessieres B; Ville Y
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):242-247. PubMed ID: 32798244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.
    Yamaguchi T; Hoshizaki M; Minato T; Nirasawa S; Asaka MN; Niiyama M; Imai M; Uda A; Chan JF; Takahashi S; An J; Saku A; Nukiwa R; Utsumi D; Kiso M; Yasuhara A; Poon VK; Chan CC; Fujino Y; Motoyama S; Nagata S; Penninger JM; Kamada H; Yuen KY; Kamitani W; Maeda K; Kawaoka Y; Yasutomi Y; Imai Y; Kuba K
    Nat Commun; 2021 Nov; 12(1):6791. PubMed ID: 34815389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia.
    Lunardi F; Fortarezza F; Vedovelli L; Pezzuto F; Boscolo A; Rossato M; Vettor R; Cattelan AM; Del Vecchio C; Crisanti A; Navalesi P; Gregori D; Calabrese F
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34073591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Expression of Angiotensin-Converting Enzyme 2 Receptor in Skin and the Implications for COVID-19.
    Al-Benna S
    Adv Skin Wound Care; 2021 Jan; 34(1):31-35. PubMed ID: 33323800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites.
    Williams TL; Strachan G; Macrae RGC; Kuc RE; Nyimanu D; Paterson AL; Sinha S; Maguire JJ; Davenport AP
    Sci Rep; 2021 Dec; 11(1):24336. PubMed ID: 34934117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manipulation of ACE2 expression in COVID-19.
    Chaudhry F; Lavandero S; Xie X; Sabharwal B; Zheng YY; Correa A; Narula J; Levy P
    Open Heart; 2020 Dec; 7(2):. PubMed ID: 33443121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.
    Eapen MS; Lu W; Hackett TL; Singhera GK; Thompson IE; McAlinden KD; Hardikar A; Weber HC; Haug G; Wark PAB; Chia C; Sohal SS
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L158-L163. PubMed ID: 33174446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity.
    Ma D; Liu S; Hu L; He Q; Shi W; Yan D; Cao Y; Zhang G; Wang Z; Wu J; Jiang C
    J Cell Mol Med; 2021 Jul; 25(14):7001-7012. PubMed ID: 34137173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19 - implications for post COVID-19 conditions.
    Ahmed G; Abdelgadir Y; Abdelghani A; Simpson P; Barbeau J; Basel D; Barrios CS; Smith BA; Schilter KF; Udani R; Reddi HV; Willoughby RE
    BMC Infect Dis; 2024 Jul; 24(1):663. PubMed ID: 38956476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 induced changes in the lungs based on autopsy cases.
    Pencheva MM; Genova SN
    Indian J Pathol Microbiol; 2023; 66(1):19-23. PubMed ID: 36656205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.